Skip to content
hatchbase

Listwell

Reads referral letters and re-triages hospital outpatient waiting lists so urgent patients are seen first

4.2(5 reviews)Healthcare AIRotterdam, Netherlands4 followers
Request a demo

Overview

Problem

Hospital outpatient waiting lists in many European health systems run to tens of thousands of patients, and a referral is usually triaged once, by a busy consultant, on the day it arrives. Patients get worse while they wait, and new information sent later by GPs, such as a lab result or a second letter, often sits unread in the record.

Solution

Listwell reads every referral letter, GP update and lab result linked to a waiting-list patient and highlights red-flag findings for the specialty, showing the source sentence. Consultants review suggested priority changes in a short daily queue, patients whose need has not changed are left alone, and clinicians make every final decision.

Target market

Public and private hospitals in the Netherlands, Germany, the Nordics and the UK running elective outpatient lists; about 2,600 acute hospitals, each spending millions a year on waiting-list management.

Business model

Annual licence per hospital, priced by the number of specialties live, typically US$90K–350K a year, plus implementation fees for record-system integration.

Demo and media

Team

  • Femke de VriesCEO and Co-founder
  • Youssef El AmraniChief Medical Officer and Co-founder
  • Joris BakkerCTO
  • Sanne VisserHead of Clinical Safety

Traction and funding

  • Hospitals live17
  • Annual recurring revenueUS$3.9M
  • Referrals reviewed410,000
  • Patients moved up2,870
Current roundNot raising right nowPrevious: Seed US$2.6M (2022), Series A US$13M (2025)

Reviews and ratings

Write a review
4.25 reviews
  • 5 stars2 reviews
  • 4 stars2 reviews
  • 3 stars1 reviews
  • 2 stars0 reviews
  • 1 star0 reviews
Sub-scores
Product
4.2
Team
4.4
Potential
3.8
  • Grace Mwangi
    Verified demoIndustry observer

    Finds the letters nobody had time to read

    The most striking cases in the demo were patients whose GPs had written a second letter weeks after referral, describing growth or bleeding, that nobody had opened. Listwell surfaced them in a short morning queue. It was less clear how it handles letters in languages other than Dutch, German and English.

  • Aisha Bello
    Verified demoCustomer

    The evidence view is what makes consultants trust it

    We evaluated Listwell for a hospital group's dermatology and ENT lists. Every suggested priority change shows the exact sentence from the GP letter or lab result, so consultants decide in under a minute rather than rereading the record. The audit page, which measures missed red flags by sampling, answered our clinical safety officer's first question.

  • Hannah Lindqvist
    Investor

    Clinical safety treated as a product feature

    Femke and Youssef built a clinical safety team before a sales team, and that is why hospitals sign. Seventeen hospitals and US$3.9M ARR after the Series A is steady progress in a market that punishes shortcuts. The audit report is something hospital boards actually read.

  • Priyanka Desai
    Investor

    Good product, slow market; not a fit for our fund's timeline

    The product is thoughtful and the clinical results are real, with 2,870 patients moved up after review. But sales cycles averaged 14 months and each hospital needs its own record integration, which caps how fast revenue can grow. For a seed fund that needs faster expansion it was not a fit, though I can see it becoming a solid long-term business.

    Reply from Femke de Vries, CEO

    Our newer contracts with hospital groups cover several sites at once, which has brought the average cycle under ten months.

Testimonials

Coming soon. Testimonials are invited by the founder and shown separately from open reviews.

Updates

Coming soon. Follow Listwell to hear about product and funding updates when this launches.

Next availableChecking times…Request a demo